Biolife Solutions Inc BLFS.O :
* BIOLIFE SOLUTIONS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* QTRLY REVENUE OF $40.7 MILLION INCREASED 21% OVER Q3 2021
* TIGHTENS 2022 REVENUE GUIDANCE RANGE REFLECTING
YEAR-OVER-YEAR
GROWTH OF 34% TO 38% AND ORGANIC GROWTH OF 37% TO 40%
* LOSS PER SHARE FOR Q3 OF 2022 WAS $0.23
* TOTAL REVENUE FOR 2022 IS NOW EXPECTED TO RANGE FROM $160
MILLION TO $164 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.17 -- REFINITIV IBES DATA
* Q3 REVENUE VIEW $42.1 MILLION -- REFINITIV IBES DATA
* FY2022 REVENUE VIEW $163.4 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn2WLg74a
Further company coverage: BLFS.O